LONG-TERM CHANGES IN PSYCHOLOGICAL SYMPTOMATOLOGY ASSOCIATED WITH HIVSEROSTATUS AMONG MALE INJECTING DRUG-USERS

Citation
Rf. Davis et al., LONG-TERM CHANGES IN PSYCHOLOGICAL SYMPTOMATOLOGY ASSOCIATED WITH HIVSEROSTATUS AMONG MALE INJECTING DRUG-USERS, AIDS, 9(1), 1995, pp. 73-79
Citations number
23
Categorie Soggetti
Immunology,"Infectious Diseases
Journal title
AIDSACNP
ISSN journal
02699370
Volume
9
Issue
1
Year of publication
1995
Pages
73 - 79
Database
ISI
SICI code
0269-9370(1995)9:1<73:LCIPSA>2.0.ZU;2-R
Abstract
Objective: To examine long-term changes in psychological symptomatolog y from 6 to 24 months after notification of HIV serostatus among male injecting drug users (IDU). Design: Self-report and interview data wer e collected at 6-month intervals as part of a longitudinal study monit oring HIV infection and risk-associated behaviors among IDU. Setting: A community-based methadone-maintenance clinic. Participants: Ninety-s even male IDU (81 HIV-seronegative, 16 HIV-seropositive), including bo th methadone-maintained and out-of-treatment IDU. Main outcome measure s: Analyses of long-term changes in psychological symptomatology assoc iated with HIV serostatus among male IDU. Results: Analyses of long-te rm changes in psychological symptomatology between groups revealed no significantly greater levels of overall psychological distress or sign ificant elevations on subscales of the Symptom Checklist-90 for HIV-se ropositive compared with HIV-seronegative male IDU. Also, no significa ntly higher scores on the Beck Depression Inventory or the psychiatric composite score of the Addiction Severity Index were observed between groups. Conclusions: Our results suggest that HIV-seropositive male I DU do not express greater levels of psychological symptomatology from 6 to 24 months following notification of seropositivity compared with HIV-seronegative male IDU. Several explanations for these findings are considered. Future work should examine why male IDU do not report sig nificant and long-term elevations in symptoms post-notification of HIV seropositivity. Also, studies of changes in psychological symptomatol ogy as a function of HIV serostatus among female IDU need to be conduc ted to assess implications for treatment interventions among this unde rserved population.